Cambrex Corp

Cambrex Corporation is an innovative life sciences company providing products, services and technologies to accelerate the development and commercialization of small molecule therapeutics.

We offer a variety of technology-driven products and services for generic and branded pharmaceuticals: APIs, Advanced intermediates, Drug delivery products, and Custom development and manufacturing.

Our R&D and cGMP manufacturing facilities are located in the US, Europe and India. 

One Meadowlands Plaza East Rutherford, NJ 07073
Tel: 201-804-3000

PharmTech News Articles

FDA issued a warning letter to Cixi Zhixin Bird Clean-Care Product Co., Ltd for violations of cGMP for finished pharmaceuticals.

The company announced an investment in a new facility in Dundalk, County Louth, Ireland.

Pharmco Laboratories received an FDA warning letter for significant violations of CGMP for finished drugs and APIs at its Florida, US facility as well as misbranding of over-the-counter (OTC) acne and sunscreen drug products.

Novo Nordisk entered a research collaboration with the University of Oxford focused on Type 2 diabetes.